GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Response Oncology Inc (GREY:ROIX) » Definitions » YoY EBITDA Growth

Response Oncology (Response Oncology) YoY EBITDA Growth : -400.00% (As of Mar. 2002)


View and export this data going back to 1989. Start your Free Trial

What is Response Oncology YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Response Oncology's YoY EBITDA Growth for the quarter that ended in Mar. 2002 was -400.00%.

Response Oncology's EBITDA per Share for the three months ended in Mar. 2002 was $-0.04.


Response Oncology YoY EBITDA Growth Historical Data

The historical data trend for Response Oncology's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Response Oncology YoY EBITDA Growth Chart

Response Oncology Annual Data
Trend Dec92 Dec93 Dec94 Dec95 Dec96 Dec97 Dec98 Dec99 Dec00 Dec01
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.73 -26.48 -39.35 -279.17 -273.20

Response Oncology Quarterly Data
Jun97 Sep97 Dec97 Mar98 Jun98 Sep98 Dec98 Mar99 Jun99 Sep99 Dec99 Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -90.85 -69.87 25.00 -188.96 -400.00

Response Oncology YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Response Oncology's YoY EBITDA Growth for the fiscal year that ended in Dec. 2001 is calculated as:

YoY EBITDA Growth (A: Dec. 2001 )
=(EBITDA per Share (A: Dec. 2001 )-EBITDA per Share (A: Dec. 2000 ))/ | EBITDA per Share (A: Dec. 2000 ) |
=(-3.885--1.041)/ | -1.041 |
=-273.20 %

Response Oncology's YoY EBITDA Growth for the quarter that ended in Mar. 2002 is calculated as:

YoY EBITDA Growth (Q: Mar. 2002 )
=(EBITDA per Share (Q: Mar. 2002 )-EBITDA per Share (Q: Mar. 2001 )) / | EBITDA per Share (Q: Mar. 2001 )) |
=(-0.039-0.013)/ | 0.013 |
=-400.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Response Oncology YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Response Oncology's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Response Oncology (Response Oncology) Business Description

Traded in Other Exchanges
N/A
Address
1775 Moriah Woods Boulevard, Memphis, TN, USA, 38117
Website
Response Oncology Inc provides cancer treatments and related services on an outpatient basis.

Response Oncology (Response Oncology) Headlines

No Headlines